Skip to main content
X4 Pharmaceuticals, Inc logo

X4 Pharmaceuticals, Inc — Investor Relations & Filings

Ticker · XFOR ISIN · US0428731097 LEI · 549300R0UFVPXWP86U94 US Manufacturing
Open in API
Filings indexed 784 across all filing types
Latest filing 2017-11-13 Regulatory Filings
Country US United States of America
Listing US XFOR

About X4 Pharmaceuticals, Inc

https://www.x4pharma.com/

X4 Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company that develops and commercializes therapies for rare diseases of the immune system. The company focuses on diseases resulting from the dysfunction of the CXCR4 pathway, a key signaling pathway for immune cell trafficking. Its lead product, XOLREMDI™ (mavorixafor), is an oral, selective antagonist of the CXCR4 receptor. It is approved for use in patients aged 12 and older with WHIM syndrome (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis) to increase the number of circulating neutrophils and lymphocytes. The company's pipeline includes further investigation of mavorixafor for other chronic neutropenic disorders.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2017
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC requesting acceleration of effectiveness for a Registration Statement on Form S-1. It references securities regulations and underwriters but does not contain financial statements or report data. The document is short (2309 characters) and is a formal regulatory communication related to a registration filing, not a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS) as a regulatory announcement rather than a report or presentation.
2017-11-13 English
Regulatory Filings 2017
Regulatory Filings Classification · 95% confidence The document is a letter from Arsanis, Inc. to the SEC requesting acceleration of the effective date of a Registration Statement on Form S-1. It references a regulatory filing (Form S-1) but does not contain financial data or the registration statement itself. The document length is short (1026 characters) and is a formal request related to a filing process, not a report or financial statement. Therefore, it fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and filings that do not fit other categories.
2017-11-13 English
S-1/A
Capital/Financing Update Classification · 95% confidence The document is a Form S-1/A Registration Statement filed with the SEC, which is used for registering securities for an initial public offering (IPO). It includes detailed information about the company, the offering, risk factors, management discussion, financial data, and underwriting details. This type of filing is related to capital raising and financing activities rather than periodic financial reporting or other categories. Therefore, it fits the Capital/Financing Update category (CAP). The document length is substantial (15,000 characters), and it is not merely an announcement or a certification, so it is not RPA or RNS. Hence, the classification is CAP with high confidence.
2017-11-06 English
Regulatory Filings 2017
Regulatory Filings Classification · 100% confidence The document is a letter from a law firm to the SEC regarding a confidential treatment request related to Arsanis, Inc.'s Registration Statement on Form S-1 for an IPO. It discusses valuation of common stock, preliminary IPO price range, and related confidential information. The document is a correspondence letter supplementing a registration statement filing, not a financial report, earnings release, or other report type. It is not a report itself but a regulatory filing related to the registration process and confidential treatment request. The document length is about 12,385 characters, but it is clearly a regulatory correspondence and not a report or announcement of a report. Therefore, the best classification is Regulatory Filings (RNS).
2017-10-26 English
Regulatory Filings 2017
Regulatory Filings Classification · 100% confidence The document is a letter addressed to the SEC Division of Corporation Finance regarding a Registration Statement on Form S-1 for Arsanis, Inc. It discusses responses to SEC staff comments on the draft Registration Statement, including detailed references to specific pages and disclosures in the Registration Statement. The Form S-1 is a registration document filed for an initial public offering (IPO) under the Securities Act of 1933. This document is not the Registration Statement itself but a correspondence letter responding to SEC comments on the Registration Statement. It is a regulatory filing related to the registration process but does not contain financial statements or the full report itself. Therefore, it should be classified as a Regulatory Filing (RNS). The document length (7,620 characters) and content confirm it is a detailed comment response letter, not a full report or prospectus.
2017-10-20 English
S-1
Capital/Financing Update Classification · 95% confidence The document is a Form S-1 Registration Statement filed with the SEC, dated October 20, 2017, for Arsanis, Inc. It is a preliminary prospectus for an initial public offering (IPO) of common stock. The text includes detailed information about the company, its business, risk factors, management, financial data, and the offering terms. Form S-1 is a registration statement used for securities offerings and is not an annual report, earnings release, or other financial report. It is a capital markets filing related to fundraising and securities issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed offering information, not just an announcement or a brief notice, so it is not a Report Publication Announcement or Regulatory Filing. Confidence is high given the clear identification of the document as a Form S-1 registration statement for an IPO.
2017-10-20 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.